Daiwa Securities Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-210
Closed -$7K 1431
2025
Q4
$7K Hold
210
﹤0.01% 1213
2025
Q3
$6K Hold
210
﹤0.01% 1193
2025
Q2
$8K Hold
210
﹤0.01% 1127
2025
Q1
$8K Hold
210
﹤0.01% 1107
2024
Q4
$10K Hold
210
﹤0.01% 1122
2024
Q3
$9K Hold
210
﹤0.01% 1138
2024
Q2
$10K Hold
210
﹤0.01% 1163
2024
Q1
$7K Hold
210
﹤0.01% 1190
2023
Q4
$8K Hold
210
﹤0.01% 1182
2023
Q3
$4K Hold
210
﹤0.01% 1181
2023
Q2
$4K Hold
210
﹤0.01% 1206
2023
Q1
$3K Hold
210
﹤0.01% 1196
2022
Q4
$5K Hold
210
﹤0.01% 1160
2022
Q3
$7K Hold
210
﹤0.01% 1148
2022
Q2
$7K Buy
210
+42
+25% +$1.49K ﹤0.01% 1153
2022
Q1
$8K Buy
168
+23
+16% +$1.27K ﹤0.01% 1153
2021
Q4
$11K Sell
145
-24
-14% -$2.46K ﹤0.01% 1147
2021
Q3
$18K Buy
169
+73
+76% +$8.36K ﹤0.01% 1110
2021
Q2
$13K Hold
96
﹤0.01% 1036
2021
Q1
$12K Buy
96
+11
+13% +$1.67K ﹤0.01% 1038
2020
Q4
$12K Sell
85
-148
-64% -$16.4K ﹤0.01% 1010
2020
Q3
$18K Buy
233
+22
+10% +$1.37K ﹤0.01% 1003
2020
Q2
$6K Hold
211
﹤0.01% 1101
2020
Q1
$6K Buy
211
+25
+13% +$672 ﹤0.01% 1094
2019
Q4
$4K Buy
+186
New +$4.35K ﹤0.01% 1132

Other funds holding TWST

Daiwa Securities Group's TWST Position: Q1 2026 in Review

Daiwa Securities Group sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 210 shares — an estimated $7K sold.

Daiwa Securities Group first reported a position in TWST in Q4 2019 and held it in 25 quarters. The position peaked at $18K in Q3 2021. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Daiwa Securities Group reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 210 Twist Bioscience shares in Q1 2026, an estimated $7K.
  • Daiwa Securities Group first reported a position in Twist Bioscience in Q4 2019 and held it in 25 quarters.
  • Daiwa Securities Group's Twist Bioscience position peaked at $18K in Q3 2021.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.